Is the $1000 Genome as Near as We Think? A Cost Analysis of Next-Generation Sequencing | Zendy

K.J.M. van Nimwegen | Zendy; Ronald A van Soest | Zendy; Joris A. Veltman | Zendy; Marcel Nelen | Zendy; Gert Jan van der Wilt | Zendy; Lisenka E.L.M. Vissers | Zendy; Janneke P.C. Grutters | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Is the $1000 Genome as Near as We Think? A Cost Analysis of Next-Generation Sequencing

Author(s) -

K.J.M. van Nimwegen,

Ronald A van Soest,

Joris A. Veltman,

Marcel Nelen,

Gert Jan van der Wilt,

Lisenka E.L.M. Vissers,

Janneke P.C. Grutters

Publication year - 2016

Publication title -

clinical chemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.705

H-Index - 218

eISSN - 1530-8561

pISSN - 0009-9147

DOI - 10.1373/clinchem.2016.258632

Subject(s) - exome sequencing , dna sequencing , whole genome sequencing , exome , genome , computational biology , hybrid genome assembly , computer science , biology , genetics , mutation , gene

The substantial technological advancements in next-generation sequencing (NGS), combined with dropping costs, have allowed for a swift diffusion of NGS applications in clinical settings. Although several commercial parties report to have broken the $1000 barrier for sequencing an entire human genome, a valid cost overview for NGS is currently lacking. This study provides a complete, transparent and up-to-date overview of the total costs of different NGS applications.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research